{"componentChunkName":"component---src-templates-chapter-level-2-chapter-level-2-tsx","path":"/topics/nappy-rash/prescribing-information/topical-imidazoles/","result":{"pageContext":{"chapter":{"id":"54149fa7-c48e-56d7-909c-d76fceaaa0b6","slug":"topical-imidazoles","fullItemName":"Topical imidazoles","depth":2,"htmlHeader":"<!-- begin field 12e96a69-0d4f-4735-a73e-a918010d7aaa --><h2>Topical imidazoles</h2><!-- end field 12e96a69-0d4f-4735-a73e-a918010d7aaa -->","summary":"","htmlStringContent":"<!-- begin item 43d4664c-054a-4f92-b02c-a918010d74b6 --><!-- end item 43d4664c-054a-4f92-b02c-a918010d74b6 -->","topic":{"id":"fced145b-8234-5cd6-8495-21dd435fa09e","topicId":"bf5cc007-7a69-42da-9cce-026e01ec0830","topicName":"Nappy rash","slug":"nappy-rash","lastRevised":"Last revised in September 2020","chapters":[{"id":"6bd868d7-97dc-5abb-9dd7-5bd8d9a45b42","fullItemName":"Summary","slug":"summary","subChapters":[]},{"id":"285ad030-4a43-587e-b95d-111b05082bd7","fullItemName":"Have I got the right topic?","slug":"have-i-got-the-right-topic","subChapters":[]},{"id":"51cba348-0401-515c-b0cb-403accf300bb","fullItemName":"How up-to-date is this topic?","slug":"how-up-to-date-is-this-topic","subChapters":[{"id":"3faf55b7-5b1b-55f9-87fa-6c77ae443435","slug":"changes","fullItemName":"Changes"},{"id":"5d2e0f7f-32f0-515c-acf8-f41a7793f377","slug":"update","fullItemName":"Update"}]},{"id":"6afe2031-7d04-5d34-8f93-9f76b0cee31f","fullItemName":"Goals and outcome measures","slug":"goals-outcome-measures","subChapters":[{"id":"df2b7ca6-faa1-5155-b6f8-e38e875710a9","slug":"goals","fullItemName":"Goals"},{"id":"c88d8b1e-a003-5fdb-8125-60256108c8fd","slug":"outcome-measures","fullItemName":"Outcome measures"},{"id":"2381dd75-9264-51ce-923a-ffd47d06fb70","slug":"audit-criteria","fullItemName":"Audit criteria"},{"id":"9148277c-7b69-5abd-96e6-6da6cdc0692c","slug":"qof-indicators","fullItemName":"QOF indicators"},{"id":"e337d403-433f-5884-ad90-0dc4725b9e10","slug":"qipp-options-for-local-implementation","fullItemName":"QIPP - Options for local implementation"},{"id":"98137183-55d3-54da-8a82-f70edd211099","slug":"nice-quality-standards","fullItemName":"NICE quality standards"}]},{"id":"2308d842-41bc-5c6e-b14f-7a732380baae","fullItemName":"Background information","slug":"background-information","subChapters":[{"id":"25c232ac-1d36-5623-a083-670842228d71","slug":"definition","fullItemName":"Definition"},{"id":"d6bc684b-0cf9-51f4-880a-68386599241c","slug":"prevalence","fullItemName":"Prevalence"},{"id":"0baab6c3-f7e8-573b-96ee-4e51d9cb5330","slug":"risk-factors","fullItemName":"Risk factors"},{"id":"8e6a2c35-a2df-5ed9-8430-1d28fa50879e","slug":"complications","fullItemName":"Complications"},{"id":"808d9af1-4926-59a3-80ef-e810780e9314","slug":"prognosis","fullItemName":"Prognosis"}]},{"id":"34a7e7aa-63d3-5df0-9b78-2d694441515e","fullItemName":"Diagnosis","slug":"diagnosis","subChapters":[{"id":"0f83f809-aed6-51e2-990d-c63ccf224d4e","slug":"diagnosis","fullItemName":"Diagnosis"},{"id":"36a8ef6d-dd7b-5e24-88b6-2e0d2e428522","slug":"assessment","fullItemName":"Assessment"},{"id":"da38cadb-36b7-5e94-a4d2-1ac880a9fc14","slug":"differential-diagnosis","fullItemName":"Differential diagnosis"}]},{"id":"512f5f04-323c-5417-9d49-118aaf08ef60","fullItemName":"Management","slug":"management","subChapters":[{"id":"e22f1fdc-9a01-51a6-9519-694c4dc68f3e","slug":"management","fullItemName":"Scenario: Management"}]},{"id":"919d8121-c385-56c1-a44a-d1b60e0744d8","fullItemName":"Prescribing information","slug":"prescribing-information","subChapters":[{"id":"54149fa7-c48e-56d7-909c-d76fceaaa0b6","slug":"topical-imidazoles","fullItemName":"Topical imidazoles"},{"id":"3e0033c5-591d-5608-8277-0cb6706398f5","slug":"flucloxacillin","fullItemName":"Flucloxacillin"},{"id":"4a82e127-a2d6-5fae-9103-e83494a28d24","slug":"clarithromycin","fullItemName":"Clarithromycin"}]},{"id":"01431b56-1a68-53cb-9666-0bc883bec5ff","fullItemName":"Supporting evidence","slug":"supporting-evidence","subChapters":[]},{"id":"186815e3-961f-5ab5-b89d-b7d341d8851a","fullItemName":"How this topic was developed","slug":"how-this-topic-was-developed","subChapters":[{"id":"c9ab642f-9b46-54ff-a595-1e9168cbfdff","slug":"search-strategy","fullItemName":"Search strategy"},{"id":"a12c552f-6d1a-5409-a5cf-dc1efba7bb2a","slug":"stakeholder-engagement","fullItemName":"Stakeholder engagement"},{"id":"d9167d23-de60-534b-b0da-c093d3a37b23","slug":"evidence-exclusion-criteria","fullItemName":"Evidence exclusion criteria"},{"id":"33ede077-9ff7-58b7-981d-d4dd371561b0","slug":"organizational-behavioural-financial-barriers","fullItemName":"Organizational, behavioural and financial barriers"},{"id":"db7928f1-0104-5ed1-8880-c59b9f060e6f","slug":"declarations-of-interest","fullItemName":"Declarations of interest"}]},{"id":"96311897-ae0a-5de9-a6a0-0cb5e181a4d3","fullItemName":"References","slug":"references","subChapters":[]}]},"parentChapter":{"id":"919d8121-c385-56c1-a44a-d1b60e0744d8","slug":"prescribing-information","fullItemName":"Prescribing information"},"subChapters":[{"id":"91cabd61-5bcd-558c-b986-d4c90a9eb9f1","slug":"contraindications-cautions","fullItemName":"Contraindications and cautions","depth":3,"htmlHeader":"<!-- begin field 03d7efa0-30e4-4d7f-87c4-a918010de772 --><h3>Contraindications and cautions</h3><!-- end field 03d7efa0-30e4-4d7f-87c4-a918010de772 -->","summary":"","htmlStringContent":"<!-- begin item 70230127-48ef-4fde-ad55-a918010de6ea --><!-- begin field 63e144b2-3b78-4c0a-bf2e-a918010de772 --><p><strong>Inform the person that when using topical imidazoles:</strong></p><ul><li>Avoid contact with the eyes and mucous membranes.</li></ul><p>[<a class=\"bibliography-reference internal-reference\" href=\"/topics/nappy-rash/references/\">BNF for Children, 2017</a>]</p><!-- end field 63e144b2-3b78-4c0a-bf2e-a918010de772 --><!-- end item 70230127-48ef-4fde-ad55-a918010de6ea -->","subChapters":[]},{"id":"30af8b59-15da-5c51-9b96-bb4459c68f82","slug":"adverse-effects","fullItemName":"Adverse effects","depth":3,"htmlHeader":"<!-- begin field 9c962b24-f758-4811-877b-a918010e01b4 --><h3>Adverse effects</h3><!-- end field 9c962b24-f758-4811-877b-a918010e01b4 -->","summary":"","htmlStringContent":"<!-- begin item 1542730a-9bdc-4252-9b01-a918010e00e7 --><!-- begin field 8e240b43-7795-4cd3-8301-a918010e01b4 --><p><strong>Topical imidazoles are generally well tolerated. Possible adverse effects include:</strong></p><ul><li>Local skin irritation, rash, erythema, itch, mild burning sensation, and hypersensitivity reactions. Treatment should be discontinued if these are severe.</li></ul><p>[<a class=\"bibliography-reference internal-reference\" href=\"/topics/nappy-rash/references/\">BNF for Children, 2017</a>]</p><!-- end field 8e240b43-7795-4cd3-8301-a918010e01b4 --><!-- end item 1542730a-9bdc-4252-9b01-a918010e00e7 -->","subChapters":[]},{"id":"dda7b9ff-9c4c-5207-a5b9-1daf848cc649","slug":"drug-interactions","fullItemName":"Drug interactions","depth":3,"htmlHeader":"<!-- begin field 5c3680a1-1c17-46ea-9ee4-a918010e25c2 --><h3>Drug interactions</h3><!-- end field 5c3680a1-1c17-46ea-9ee4-a918010e25c2 -->","summary":"","htmlStringContent":"<!-- begin item f4849224-e6c3-4c86-a80f-a918010e2535 --><!-- begin field 8744113b-4739-4b09-9578-a918010e25c2 --><p><strong>Possible drug interactions with topical imidazoles include:</strong></p><ul><li>Oral miconazole and econazole are known to inhibit CYP450 enzymes, but due to the limited systemic availability of topical preparations, clinically relevant interactions are rare.<ul><li>The effect of oral anticoagulants (such as warfarin) may be enhanced by topical miconazole or econazole. Monitor the person’s international normalised ratio (INR) during concurrent use of topical miconazole or econazole with an oral anticoagulant, and adjust the warfarin dose accordingly.</li></ul></li><li>There are no known significant drug interactions with topical clotrimazole.</li></ul><p>[<a class=\"bibliography-reference internal-reference\" href=\"/topics/nappy-rash/references/\">ABPI, 2015a</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/nappy-rash/references/\">ABPI, 2015b</a>]</p><!-- end field 8744113b-4739-4b09-9578-a918010e25c2 --><!-- end item f4849224-e6c3-4c86-a80f-a918010e2535 -->","subChapters":[]},{"id":"55a424d5-4179-5ff5-8d06-87e7322cfc29","slug":"application-regimens","fullItemName":"Application regimens","depth":3,"htmlHeader":"<!-- begin field 895e4889-513d-4182-a988-a918010e4070 --><h3>Application regimens</h3><!-- end field 895e4889-513d-4182-a988-a918010e4070 -->","summary":"","htmlStringContent":"<!-- begin item 23a2b0c7-0155-447f-9553-a918010e3fd9 --><!-- begin field 87324398-bca7-49c8-b3f9-a918010e4070 --><p><strong>When applying topical imidazoles, advise that only a thin layer of cream should be used to prevent moisture entrapment.</strong></p><ul><li>Topical clotrimazole 1% is licensed for the treatment of vulval candidiasis.<ul><li>Advise the person to apply topical clotrimazole to the affected area 2 to 3 times daily for at least two weeks after the affected area has healed.</li></ul></li><li>Topical miconazole 2% is licensed for treatment of fungal skin infections.<ul><li>Advise the person to apply topical miconazole to the affected area twice daily. Treatment should be continued for 10 days after lesions have healed.</li></ul></li><li>Topical econazole 1% is licensed for the treatment of fungal skin infections.<ul><li>Advise the person to apply topical econazole to the affected area twice daily. Treatment should be continued until all skin lesions are healed.</li></ul></li></ul><p>[<a class=\"bibliography-reference internal-reference\" href=\"/topics/nappy-rash/references/\">ABPI Medicines Compendium, 2015</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/nappy-rash/references/\">ABPI, 2015a</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/nappy-rash/references/\">ABPI, 2015b</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/nappy-rash/references/\">BNF for Children, 2017</a>]</p><!-- end field 87324398-bca7-49c8-b3f9-a918010e4070 --><!-- end item 23a2b0c7-0155-447f-9553-a918010e3fd9 -->","subChapters":[]}]}}},"staticQueryHashes":["3666801979"]}